{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:26:21Z","timestamp":1784204781082,"version":"3.55.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:31:43Z","timestamp":1494549103000},"page":"3355-3363","source":"Crossref","is-referenced-by-count":66,"title":["Correlates of protection for enteric vaccines"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1784-5918","authenticated-orcid":false,"given":"Jan","family":"Holmgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh D.","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Peing","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Desauziers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Picot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Saadatian-Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2017.05.005_b0005","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/cis238","article-title":"Nomenclature for immune correlates of protection after vaccination","volume":"54","author":"Plotkin","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.005_b0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9888","key":"10.1016\/j.vaccine.2017.05.005_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"issue":"10051","key":"10.1016\/j.vaccine.2017.05.005_b0020","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0025","doi-asserted-by":"crossref","first-page":"e0004330","DOI":"10.1371\/journal.pntd.0004330","article-title":"Vibrio cholerae biofilms and cholera pathogenesis","volume":"10","author":"Silva","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.05.005_b0030","unstructured":"Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren J. Cholera. Lancet. 2017 Mar 10. . pii: S0140-6736(17)30559-7[Epub ahead of print, Review]."},{"issue":"23","key":"10.1016\/j.vaccine.2017.05.005_b0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM198306093082304","article-title":"Protection against cholera in breast-fed children by antibodies in breast milk","volume":"308","author":"Glass","year":"1983","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.005_b0040","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/IAI.55.5.1116-1120.1987","article-title":"Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin","volume":"55","author":"Black","year":"1987","journal-title":"Infect Immun"},{"issue":"8684","key":"10.1016\/j.vaccine.2017.05.005_b0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.05.005_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with vibrio cholera O1 El Tor","author":"Chen","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","article-title":"Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR","volume":"166","author":"Tacket","year":"1992","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.005_b0060","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","article-title":"Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination","volume":"67","author":"Tacket","year":"1999","journal-title":"Infect Immun"},{"issue":"22","key":"10.1016\/j.vaccine.2017.05.005_b0065","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.005_b0070","first-page":"777","article-title":"The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients","volume":"38","author":"Mosley","year":"1968","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0075","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1371\/journal.pntd.0000221","article-title":"Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh","volume":"2","author":"Harris","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/infdis\/145.4.465","article-title":"Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholera","volume":"145","author":"Clements","year":"1982","journal-title":"J Infect Dis"},{"issue":"30","key":"10.1016\/j.vaccine.2017.05.005_b0085","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.vaccine.2013.04.066","article-title":"Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: a tool for assessing immunological memory","volume":"31","author":"Leach","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.005_b0090","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fimmu.2014.00516","article-title":"Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward","volume":"5","author":"Sztein","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2017.05.005_b0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12967-016-0819-7","article-title":"Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans","volume":"14","author":"Fresnay","year":"2016","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.005_b0100","doi-asserted-by":"crossref","first-page":"e1004914","DOI":"10.1371\/journal.ppat.1004914","article-title":"Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S Typhi challenge model","volume":"11","author":"McArthur","year":"2015","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.005_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.10.019","volume":"21","author":"Qiu","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.005_b0110","doi-asserted-by":"crossref","first-page":"e82601","DOI":"10.1371\/journal.pone.0082601","article-title":"Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh","volume":"8","author":"Ud-Din","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.005_b0115","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1128\/IAI.64.10.4074-4077.1996","article-title":"Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers","volume":"64","author":"Cohen","year":"1996","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0120","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/clinids\/15.2.346","article-title":"Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides","volume":"15","author":"Robbins","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0125","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/JCM.29.2.386-389.1991","article-title":"Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis","volume":"29","author":"Cohen","year":"1991","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.005_b0130","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/infdis\/157.5.1068","article-title":"Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population","volume":"157","author":"Cohen","year":"1988","journal-title":"J Infect Dis"},{"issue":"9046","key":"10.1016\/j.vaccine.2017.05.005_b0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.005_b0140","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.vaccine.2009.12.050","article-title":"Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1\u20134-year-old Israeli children","volume":"28","author":"Passwell","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.005_b0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clim.2013.03.009","article-title":"Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a","volume":"148","author":"Wahid","year":"2013","journal-title":"Clin Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0150","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"issue":"8778","key":"10.1016\/j.vaccine.2017.05.005_b0155","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","article-title":"Prevention of travellers' diarrhoea by oral B-subunit\/whole-cell cholera vaccine","volume":"338","author":"Peltola","year":"1991","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.005_b0160","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1128\/IAI.00459-07","article-title":"Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh","volume":"75","author":"Qadri","year":"2007","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0165","doi-asserted-by":"crossref","first-page":"e2822","DOI":"10.1371\/journal.pntd.0002822","article-title":"Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults","volume":"8","author":"Alam","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.005_b0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/CVI.00526-15","article-title":"Enumeration of Gut-Homing \u03b27-Positive, pathogen-specific antibody-secreting cells in whole blood from enterotoxigenic escherichia coli- and vibrio cholerae-infected patients, determined using an enzyme-linked immunosorbent spot assay technique","volume":"23","author":"Bhuiyan","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0175","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/erv.12.12","article-title":"Recent progress toward an enterotoxigenic Escherichia coli vaccine","volume":"11","author":"Svennerholm","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"52","key":"10.1016\/j.vaccine.2017.05.005_b0180","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0185","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/427662","article-title":"Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea","volume":"191","author":"Rao","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.005_b0190","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/CMR.00006-15","article-title":"Global Epidemiology of Campylobacter Infection","volume":"28","author":"Kaakoush","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.005_b0195","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","article-title":"Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)","volume":"3","author":"Platts-Mills","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.005_b0200","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.00055-07","article-title":"Host-pathogen interactions in Campylobacter infections: the host perspective","volume":"21","author":"Janssen","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.005_b0205","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/infdis\/168.3.754","article-title":"Campylobacter immunity and quantitative excretion rates in Thai children","volume":"168","author":"Taylor","year":"1993","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.005_b0210","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/cid\/cit454","article-title":"Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model","volume":"57","author":"Kirkpatrick","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0215","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1128\/IAI.01021-09","article-title":"Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans","volume":"78","author":"Tribble","year":"2010","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.005_b0220","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1086\/644622","article-title":"Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects","volume":"49","author":"Tribble","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.005_b0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.005_b0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.05.005_b0235","doi-asserted-by":"crossref","first-page":"c2825","DOI":"10.1136\/bmj.c2825","article-title":"Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study","volume":"340","author":"de Palma","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa0905211","article-title":"Effect of rotavirus vaccination on death from childhood diarrhea in Mexico","volume":"362","author":"Richardson","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0245","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1542\/peds.2009-1021","article-title":"Effectiveness ofpentavalent rotavirus vaccine in a large urban population in the United States","volume":"125","author":"Boom","year":"2010","journal-title":"Pediatrics"},{"issue":"9601","key":"10.1016\/j.vaccine.2017.05.005_b0250","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacyof human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"issue":"9741","key":"10.1016\/j.vaccine.2017.05.005_b0255","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"issue":"9741","key":"10.1016\/j.vaccine.2017.05.005_b0260","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0270","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/S2214-109X(15)00270-3","article-title":"Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis","volume":"4","author":"Ngabo","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.005_b0275","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/317619","article-title":"Serum antibody as a marker of protection against natural rotavirus infection and disease","volume":"182","author":"Vel\u00e1zquez","year":"2000","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.05.005_b0280","doi-asserted-by":"crossref","first-page":"A55","DOI":"10.1016\/j.vaccine.2014.04.077","article-title":"Association of serum antibodies with protection against rotavirus infection and disease in South Indian children","volume":"32","author":"Premkumar","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0285","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4161\/hv.27097","article-title":"Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine","volume":"10","author":"Cheuvart","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0290","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/infdis\/jit166","article-title":"A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy","volume":"208","author":"Patel","year":"2013","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.005_b0295","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.4161\/hv.34361","article-title":"Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges","volume":"10","author":"Angel","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.05.005_b0300","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2893.2008.01029.x","article-title":"Incidence of Hepatitis A in Argentina after vaccination","volume":"15","author":"Vacchino","year":"2008","journal-title":"J Viral Hepat"},{"issue":"7532","key":"10.1016\/j.vaccine.2017.05.005_b0305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature13806","article-title":"Hepatitis A virus and the origins of picornaviruses","volume":"517","author":"Wang","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0310","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tim.2013.10.005","article-title":"Peek-a-boo: membrane hijacking and the pathogenesis of viral hepatitis","volume":"22","author":"Feng","year":"2014","journal-title":"Trends Microbiol"},{"issue":"7445","key":"10.1016\/j.vaccine.2017.05.005_b0315","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature12029","article-title":"A pathogenic picornavirus acquires an envelope by hijacking cellular membranes","volume":"496","author":"Feng","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.05.005_b0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coviro.2015.01.003","article-title":"Reassessing immune control of hepatitis A virus","volume":"11","author":"Walker","year":"2015","journal-title":"Curr Opin Virol"},{"issue":"42","key":"10.1016\/j.vaccine.2017.05.005_b0325","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1016\/j.vaccine.2015.07.008","article-title":"Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions","volume":"33","author":"Theeten","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.005_b0330","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MOG.0000000000000022","article-title":"Epidemiology of human noroviruses and updates onvaccine development","volume":"30","author":"Ramani","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"18","key":"10.1016\/j.vaccine.2017.05.005_b0335","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJMra0804575","article-title":"Norovirus gastroenteritis","volume":"361","author":"Glass","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.005_b0340","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(14)70767-4","article-title":"Global prevalence of norovirus in cases of gastroenteritis: asystematic review and meta-analysis","volume":"14","author":"Ahmed","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.005_b0345","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMsa1206589","article-title":"Norovirus and medically attended gastroenteritis in U.S. children","volume":"368","author":"Payne","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0350","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM197707142970204","article-title":"Clinical immunity in acute gastroenteritis caused by Norwalk agent","volume":"297","author":"Parrino","year":"1977","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.005_b0355","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/infdis\/151.1.99","article-title":"Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands","volume":"151","author":"Ryder","year":"1985","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.005_b0360","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/CVI.00196-15","article-title":"Serological Correlates of Protection against a GII.4 Norovirus","volume":"22","author":"Atmar","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.005_b0365","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.005_b0370","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/161.1.18","article-title":"Multiple-challenge study ofhost susceptibility to Norwalk gastroenteritis in US adults","volume":"161","author":"Johnson","year":"1990","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.005_b0375","doi-asserted-by":"crossref","first-page":"e1001807","DOI":"10.1371\/journal.pmed.1001807","article-title":"Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial","volume":"12","author":"Lindesmith","year":"2015","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.005_b0380","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/jiv053","article-title":"Mucosal and cellular immune responses to Norwalk virus","volume":"212","author":"Ramani","year":"2015","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2017.05.005_b0385","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/infdis\/jiu361","article-title":"High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children","volume":"210","author":"Malm","year":"2014","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.005_b0390","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/eid2006.131627","article-title":"Sequential gastroenteritis episodes caused by 2 norovirus genotypes","volume":"20","author":"Parra","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0395","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/cid\/cit763","article-title":"Multiple norovirus infections in a birth cohort in a Peruvian Periurban community","volume":"58","author":"Saito","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0400","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.10.046","article-title":"Leukocyte trafficking to the small intestine and colon","volume":"150","author":"Habtezion","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.005_b0405","doi-asserted-by":"crossref","first-page":"e0146010","DOI":"10.1371\/journal.pone.0146010","article-title":"Human circulating antibody-producing B cell as a predictive measure of mucosal immunity to poliovirus","volume":"11","author":"Dey","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.005_b0410","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/infdis\/153.6.1126","article-title":"Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi","volume":"153","author":"Kantele","year":"1986","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.005_b0415","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0264-410X(90)90088-4","article-title":"Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine","volume":"8","author":"Kantele","year":"1990","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.005_b0420","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0264-410X(91)90129-T","article-title":"Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine","volume":"9","author":"Kantele","year":"1991","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2017.05.005_b0425","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1016\/j.vaccine.2012.10.002","article-title":"Live oral typhoid vaccine Salmonella Typhi Ty21a \u2013 a surrogate vaccine against non-typhoid salmonella?","volume":"30","author":"Kantele","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.005_b0430","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/426943","article-title":"Unique characteristics of the intestinal immune system as an inductive site after antigen reencounter","volume":"191","author":"Kantele","year":"2005","journal-title":"J Infect Dis"},{"issue":"42","key":"10.1016\/j.vaccine.2017.05.005_b0435","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2012.07.051","article-title":"Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination","volume":"30","author":"Pakkanen","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.005_b0440","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/sji.12151","article-title":"Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains","volume":"79","author":"Pakkanen","year":"2014","journal-title":"Scand J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.005_b0445","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.vaccine.2012.12.063","article-title":"Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA\/I overexpressing bacteria and recombinantly produced LTB\/CTB hybrid protein","volume":"31","author":"Lundgren","year":"2013","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.005_b0450","doi-asserted-by":"crossref","first-page":"e51718","DOI":"10.1371\/journal.pone.0051718","article-title":"The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens","volume":"7","author":"Leach","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.005_b0455","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.05.005_b0460","series-title":"Cholera vaccines","first-page":"141","author":"Clemens","year":"2012"},{"key":"10.1016\/j.vaccine.2017.05.005_b0465","unstructured":"Correlates of vaccine-induced protection: methods and implication. WHO\/IVB\/13.01 <http:\/\/www.who.int\/iris\/bitstream\/10665\/84288\/1\/WHO_IVB_13.01_eng.pdf> [accessed on 12.09.2016]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T10:15:18Z","timestamp":1602065718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17306035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":93,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17306035"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}